A new combination of drugs was approved by the U.S. FDA for treating certain patients with advanced colorectal cancer whose disease has worsened despite treatment with chemotherapy and a biological therapy.
Study presented at the AACR’s eighth annual cancer health disparities conference examines how improved diet reduced the risk of ovarian cancer in some African-American women. Despite the substantial progress made in preventing and treating...
Finding the latest discoveries in breast cancer care together. More than 7,000 breast cancer researchers, survivors, advocates, and others from 95 countries attended the 2015 San Antonio Breast Cancer Symposium (SABCS) in early December....
The former president, who announced in August 2015 he had metastatic melanoma, recently said he was cancer-free after treatment with pembrolizumab.
Two studies show that breast-conserving surgery plus radiation may be a better choice than mastectomy plus reconstruction for women with early-stage breast cancer because the first option reduces complications, improves long-term survival and costs...
Researchers find some physicians are missing opportunities to protect today's young people from future HPV-related cancers.
Researchers are working to expand CAR T-cell immunotherapy successes against blood cancers to solid tumors.
Precision medicine is the tailoring of treatment to the individual characteristics of each patient and his or her disease.
Non-Hispanic blacks are more likely to have an aggressive form of endometrial cancer and are more likely to die from it.
Investigators found that depressed mood and poor health-related quality of life among spouses may make the cancer survivors depressed too.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More